The RUNX family in breast cancer: relationships with estrogen signaling

N-O Chimge1, B Frenkel

  • 1Department of Biochemistry and Molecular Biology, Institute for Genetic Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, CA 90033, USA. chimgee@usc.edu

Oncogene
|October 10, 2012
PubMed

Insights

RUNX proteins act as tumor suppressors or oncogenes in breast cancer (BCa). RUNX1 and RUNX3 inhibit BCa, while RUNX2 has context-dependent roles in metastasis, requiring patient selection for therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • RUNX proteins are master regulators with context-dependent roles in cancer.
  • Their involvement in breast cancer (BCa) ranges from tumor suppression to oncogenesis.
  • RUNX1 is predominant in breast epithelial cells and frequently mutated in BCa.

Purpose of the Study:

  • To review the evidence for RUNX family member roles in breast cancer.
  • To elucidate the dual roles of RUNX proteins as tumor suppressors and oncogenes in BCa.
  • To explore the implications of RUNX protein functions in BCa metastasis and therapeutic strategies.

Main Methods:

  • Review of existing literature and evidence on RUNX family members in breast cancer.
  • Analysis of somatic mutations in primary tumor biopsies.
  • Examination of gene inactivation and haploinsufficiency studies in mouse models.
  • Investigation of interactions with estrogen signaling pathways.

Main Results:

  • RUNX1 and RUNX3 exhibit tumor suppressor activities in BCa, partly via antagonism of estrogen signaling.
  • RUNX2, while a tumor suppressor in some contexts, is implicated in BCa metastasis, particularly bone metastasis.
  • Estrogen inhibition of RUNX2 may contribute to its context-dependent anti-metastatic roles in non-osseous sites.
  • Estrogen receptor alpha (ERα) is linked to increased skeletal dissemination of BCa cells.

Conclusions:

  • RUNX proteins have complex, context-dependent roles in breast cancer progression and metastasis.
  • RUNX1 and RUNX3 function as tumor suppressors, while RUNX2 has paradoxical roles in metastasis.
  • Understanding RUNX protein functions and their interaction with estrogen signaling is crucial for BCa treatment.
  • Future RUNX-based therapies will necessitate careful patient stratification based on BCa subtype and expression patterns.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...